NDC codes

FDA NDC Directory
Product NDC (as listed)16729-400Labeler and product segments. Claims need a package NDC.
Product NDC at billing width16729-0400Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
16729-400-10167290400101672904001030 TABLET, FILM COATED in 1 BOTTLE (16729-400-10)Marketed from Mar 13, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Teriflunomide
Generic name (nonproprietary)
teriflunomide
Active ingredients
Teriflunomide — 14 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Labeler
Accord Healthcare Inc.NDC labeler code 16729
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 209690
Marketing start
Listing expires
Other FDA classes
Dihydroorotate Dehydrogenase Inhibitors (Mechanism)
Identifiers
Product ID 16729-400_44e80dd3-d2da-1271-e063-6394a90aa672SPL ID 44e80dd3-d2da-1271-e063-6394a90aa672SPL set ID 246d42e5-5418-42ba-aff9-ae399b166c69RxCUI 1310525, 1310533UNII 1C058IKG3B
Pharmacologic class
Pyrimidine Synthesis Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N416729040010 followed by a unit qualifier and the quantity

Package 16729-0400-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Teriflunomide tablets are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Teriflunomide is a pyrimidine synthesis inhibitor indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 16729-400

What is NDC 16729-400?
16729-400 is the product NDC for Teriflunomide, Teriflunomide 14 mg/1 tablet, film coated, listed with the FDA by Accord Healthcare Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Teriflunomide.
What is the active ingredient?
Teriflunomide.
Who is the labeler?
Accord Healthcare Inc., NDC labeler code 16729. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Teriflunomide?
33 other product NDCs are listed under this name. See all Teriflunomide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Teriflunomide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCivica Script LLC82249-11182249-0111-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralCivica Script LLC82249-11282249-0112-30
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralCONCORD BIOTECH LIMITED68254-501368254-5013-01
TeriflunomideTeriflunomide 14 mg/141Tablet, Film coatedOralCONCORD BIOTECH LIMITED68254-501068254-5010-01
TeriflunomideTeriflunomide 7 mg/1TabletOralNatco Pharma USA LLC69339-16969339-0169-0369339-0169-0969339-0169-93
TeriflunomideTeriflunomide 14 mg/1TabletOralNatco Pharma USA LLC69339-17069339-0170-0369339-0170-0969339-0170-93
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralAvKARE42291-83042291-0830-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralAvKARE42291-83142291-0831-30
TeriflunomideTeriflunomide 14 mg/1Tablet, Film coatedOralBiocon Pharma Inc.70377-01870377-0018-1170377-0018-91
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralBiocon Pharma Inc.70377-01770377-0017-1170377-0017-91

All 34 Teriflunomide NDCs

Other NDCs under ANDA 209690

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 209690
ProductStrengthForm · routeLabelerProduct NDC
TeriflunomideTeriflunomide 7 mg/1Tablet, Film coatedOralAccord Healthcare Inc.16729-399

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in